Adam Mullick

Adam Mullick has extensive experience in drug discovery, particularly in the fields of cardiovascular, metabolic, and renal diseases. Currently serving as Vice President of Cardiovascular and Renal Drug Discovery at Ionis Pharmaceuticals, Inc. since March 2007, Adam has held various leadership roles including Executive Director and Director within the organization, focusing on antisense approaches and tissue targeting strategies for drug development. Prior to joining Ionis, Adam completed postdoctoral work at The Scripps Research Institute and earned a Ph.D. in Molecular, Cellular, and Integrative Physiology, as well as a Bachelor of Science in Neurobiology, Physiology, and Behavior from the University of California, Davis.